Company receives federal license to manufacture and sell cannabis
Maridose LLC has received a Federal license from the United States Department of Justice and Drug Enforcement Agency for the bulk manufacture of cannabis to supply researchers with any or all of the following Schedule 1 products: cannabis, cannabis extract (including isolated chemical constituents), and tetrahydrocannabinols (THC).
For decades the University of Mississippi had a monopoly on cannabis grown for research. The license granted to Maridose is a step toward ending that monopoly and expanding access to modern cannabis strains for research on cannabis and cannabis-derived products.
Related: 22nd Century Group Receives USDA Organic Certification for Hemp
Maridose is now an alternative to the University of Mississippi and is licensed by the Drug Enforcement Agency to supply cannabis and its extracts for research use in the United States.
“We are very excited to receive this license from the DEA to produce and sell cannabis for research purposes. This a huge step for science and the future of cannabis.”, said Richard Shain, Maridose’s Founder, “Our DEA Registration Number RM063095 is the culmination of over five years of working with the DEA and enables Maridose to legally sell a wide variety of cannabis products through the DEA to researchers and DEA-licensed pharmaceutical companies in the United States and internationally. The DEA has indicated that it will only issue a very limited number of them, and Maridose is proud to be one of the first companies to receive a license. Cannabis businesses operating in states that have state-legal cannabis are unable to ship across state lines and operate at legal risk because cannabis remains a Schedule 1 substance at the federal level. Maridose is able to legally supply our customers without these risks and limitations.”
For more information:
Maridose
www.maridose.com
Company receives federal license to manufacture and sell cannabis
About Cannin: Your Cannabis Stocks Resource
78% of Cannin’s fundamentals prove true within 30 days or less on 100+ recommendations over the past 2 years.
Cannin is your #1 trusted resource for cannabis stocks. Our global team of experts evaluates all emerging cannabis stock investing opportunities. In fact, we aggregate hundreds of hours of financial research and provide tips on the best cannabis stocks for 2021.
Use Cannin as your resource for:
Market analysts expect the marijuana and hemp industry will have an annual value exceeding $75 Billion in the next decade. Is it too late to invest in marijuana stocks? No! This is the perfect time to invest.
Are you looking to buy stock in hemp companies or marijuana companies for 2021? If so, are you interested in new penny hemp stock companies? Or, looking for the best Canadian cannabis stocks to invest in? Maybe, you’re looking to leverage the power of algorithmic stock trading to beat the cannabis market? We can help.
Are you interested in cannabis stocks like Curaleaf, Trulieve, Aurora Cannabis, Charlotte’s Web, Canopy Growth, or Hemp Inc.?
Predict price movements of cannabis stocks several hours in advance with our proprietary algorithmic stock trading software.
- +34% Gains in 2022
- +56% Gains in 2021
- +30% Gains in 2020
- +49.8% Gains in 2019
- Backtested since 2012
In fact, we’re so confident you’ll love our algotrading cannabis stock signals, we’re willing to give you a one week risk-free trial to see it for yourself.
Profit from the best cannabis stocks – we’ll show you how at cannin.com.
